Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Re-usable Respimat® Soft MistTM Inhaler Study
Clinical trial update for a re-usable Respimat Soft Mist inhaler in chronic obstructive pulmonary disease; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial assessing safety and tolerability of PT010, PT009, and PT003 in moderate to very severe COPD completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study [NA]
Clinical trial completed evaluating psychological risk factors influencing smoking persistence in COPD patients; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Home-Based Health Management of COPD Patients [NA]
Completed clinical trial on home-based health management for chronic obstructive pulmonary disease (COPD) with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 clinical trial evaluating long-term nitric oxide bioavailability and vascular health in COPD has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency [Phase 2]
Phase 2 clinical trial update investigating targeting pulmonary perfusion in alpha-1 antitrypsin deficiency with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.
A completed clinical trial (OPTI Study in Spain) evaluating history flare-ups in COPD patients treated with inhaled steroids; results posted…
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Implementing and Evaluating the Genie Tool in COPD [NA]
A completed clinical trial evaluating the Genie Tool in COPD and Emphysema with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Evaluation the Effectiveness of a Telemonitoring Program in a Cohort of COPD Patient With Frequent Readmissions [NA]
A completed clinical trial evaluated the effectiveness of a telemonitoring program for COPD patients with frequent readmissions; results wer…
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD [Phase 3]
A Phase 3 trial assessing the effects of BGF and GFF on image-based airway volumes and resistance in adults with moderate to severe COPD has…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 study evaluating CK-2127107 on physical function in adults with chronic obstructive pulmonary disease has completed, with results …
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Non-inferiority Evaluation of Trimbow in Critically Ill Patients Admitted in ICU Compared to Standard of Care [Phase 4]
A Phase 4 trial evaluating non-inferiority of Trimbow versus standard of care in critically ill COPD_exacerbation patients admitted to ICU.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) [Phase 3]
Phase 3 trial comparing PT010 to PT003 and PT009 in moderate to very severe COPD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial update for SUN11031 in cachexia associated with COPD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia [Phase 2]
Phase 2 proof-of-mechanism study of multiple oral doses of Fevipiprant (QAW039) in COPD patients with eosinophilia; study terminated with po…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial evaluating beta-blockers to prevent acute exacerbations in chronic obstructive pulmonary disease; terminated with posted resul…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI [Phase 2, Phase 3]
Phase 2/3 trial evaluating Bevespi's effects on ventilation and gas exchange abnormalities in COPD using 129Xe MRI; study completed with res…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial investigating lovastatin as a potential modulator of apoptosis in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial update on Symbicort in airway-predominant COPD completed.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects [Phase 1]
Phase 1 pharmacokinetics and safety study of PT010 and PT003 in healthy Chinese adults completed. Results posted.
-
FDA approval · 2021-01-14FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application from Lupin Pharmaceuticals for albuterol sulfate, confirming approval of a generic inhalation produc…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD [NA]
A completed clinical trial assessing the impact of physical activity promotion on short- and long-term outcomes in COPD.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. [Phase 2]
A Phase 2 trial evaluating a vaccine for COPD to reduce episodes of worsening symptoms and assess safety and immune response; study complete…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial investigating how chlorhexidine affects oral and lung microbiota in chronic obstructive pulmonary disease (COPD); study comple…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos) [Phase 3]
A Phase 3 randomized trial comparing PT010, PT003, and PT009 with Symbicort in chronic dosing for chronic obstructive pulmonary disease (COP…